The Motley Fool Discussion Boards

Previous Page

Investors' Roundtable / Rule Maker Companies


Subject:  PFE Date:  11/3/1999  9:49 AM
Author:  gregbeckstrom Number:  4563 of 8329

Phil's focus on the fiscal management (cash conversion cycle)of PFE, SP & Warner Lambert fails to recognize the importance of product pipeline (R&D)and marketing prowess. I think those two items are more important to the long-term viability of a pharmecutical company. Cash turnover is more important in the start up phase of an organization. It's possible that Warner's management has to focus on finances because it's the best tool in their tool box. My concern here is that I've seen companies run tight ships right onto the rocks.
Copyright 1996-2022 trademark and the "Fool" logo is a trademark of The Motley Fool, Inc. Contact Us